News Article

The Nordic care sector has witnessed a significant consolidation, as Ambea AB has completed its takeover of Humana AB creating a powerhouse in the regional healthcare market.

By acquiring 98 per cent of Humana’s outstanding shares, the market leading Nordic care provider has successfully combined two of the most prominent care providers in Sweden, Norway, and Finland. This transaction marks a strategic milestone for Ambea as it seeks to strengthen its position across all four major Nordic countries.

The acquisition involved a total purchase consideration of SEK 3,423 million (£260m). Investors have closely monitored the deal, which saw Ambea issue over 8.6 million new shares to satisfy the share consideration portion of the offer. Following the successful tender, Ambea has initiated compulsory redemption proceedings for the remaining minority shares and delisted Humana from Nasdaq Stockholm, with the final day of trading on October 27.

For operators, the integration process is now a primary focus, with Humana being consolidated into Ambea’s financial reporting from October 1. Ambea management has highlighted that the combination will create a broader platform for future growth and enhance the ability to invest in quality and innovation. However, the group also intends to streamline operations by divesting Humana’s Swedish personal assistance business within the next twelve months to focus on core care services.

Ambea’s third quarter results released at the start of November provided the first detailed look at transaction costs and the integration roadmap. The deal materially increases group earnings and sales estimates by approximately 45 per cent for 2027, though the initial phase involves significant integration expenses.